CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 128 enrolled
Drug / intervention
Cholecalciferol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01384539
NCT01384539Phase 3Completed
CompareCT.gov

Vitamin D and Arterial Function in Patients With Chronic Kidney Disease

University of Colorado, Denver·interventional·Posted Jun 29, 2011·Updated Sep 28, 2018

In Brief

A Phase 3 clinical trial evaluating Cholecalciferol and Calcitriol for Arterial Dysfunction and Chronic Kidney Disease. Completed, enrolled 128 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether nutritional (cholecalciferol) or active vitamin D (calcitriol) supplementation improves vascular endothelial function in patients with stage IIIB and IV chronic kidney disease with vitamin D insufficiency or deficiency. The investigators hypothesize that the use of calcitriol supplementation will result in improved vascular endothelial function as compared to cholecalciferol supplementation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArterial Dysfunction, Chronic Kidney Disease
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJun 29, 2011
Enrollment StartJul 1, 2011
Primary CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 15.0 years ago

Interventions

Cholecalciferoldrug

Calcitrioldrug